European Monitoring Centre for Drugs and Drug Addiction. (2021) Risk assessment report on a new psychoactive substance: methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-car- bonyl]amino}butanoate (MDMB-4en-PINACA) in accordance with Article 5c of Regulation (EC) No 1920/2006 (as amended). Lisbon: European Monitoring Centre for Drugs and Drug Addiction.
| Preview | Title | Contact |
|---|---|---|
|
PDF (Risk assessment: MDMB-4en-PINACA)
645kB |
This risk assessment report presents the summary findings and the conclusion of the risk assessment carried out by the Scientific Committee of the EMCDDA on MDMB-4en- PINACA. The report is intended for policymakers and decision-makers in the institutions of the EU.
Table of contents
- Statement regarding the United Kingdom
- Contents
- Introduction
- Background
- Pharmacological and toxicological properties
- Health risks
- Social risks
- Extent and patterns of use, availability and potential for diffusion
- Commercial and industrial uses, the extent of such use and its use for scientific research and developmental purposes
- Other relevant information
- Conclusion
B Substances > New (novel) psychoactive substances > Synthetic cannabinoids (Spice / K2 / OXIZID / HHC)
E Concepts in biomedical areas > Pharmacology and toxicology
J Health care, prevention, harm reduction and treatment > Risk and needs assessment > Risk assessment
L Social psychology and related concepts > Legal availability or accessibility
MM-MO Crime and law > Substance use laws > Drug laws
VA Geographic area > Europe
VA Geographic area > Europe > Ireland
Repository Staff Only: item control page